OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today announced that members of management will participate in the following upcoming investor conferences in March:
Live webcasts of the company presentations will be available on the Company�s website, under the Investors & Media section at www.investors.exscientia.ai. Archived replays of the webcasts will be available for approximately 30 days following the presentation.
About Exscientia
Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.
Visit us at https://www.exscientia.ai or follow us on Twitter @exscientiaAI.
Contacts
Investor Relations Contact:
Sara Sherman
investors@exscientia.ai
Media Contact:
Oliver Stohlmann
media@exscientia.ai
SINGAPORE--(BUSINESS WIRE)--Hafnia Limited (“Hafnia”, the “Company”, OSE ticker code: “HAFNI”, NYSE ticker code “HAFN”) will…
PHNOM PENH, Cambodia--(BUSINESS WIRE)--Google Cloud and the Overseas Cambodian Investment Corporation (“OCIC”) joined forces to…
SYDNEY, AUSTRALIA - Media OutReach Newswire - 10 May 2024 - SolarWinds (NYSE:SWI), a leading…
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 10 May 2024 - ZF Aftermarket, renowned…
HONG KONG SAR - Media OutReach Newswire - 10 May 2024 - DFI Retail Group…
LOUGHBOROUGH, England--(BUSINESS WIRE)--The Access Group, a leading provider of business management software to mid-market organisations…